We are a full service Agent for many well known multinational companies for whom we provide market research, product registration and package design, marketing strategy and implementation, medical detailing and merchandising, product import and distribution.Our goal: to be the premier marketing and distribution company of health care products in Ukraine and then the Commonwealth of Independent States (CIS). In addition, Delta provides clinical trials, registration and publishes a specialized pharmacy trade magazine.The past 10 years have seen us expand to over 500 employees in Ukraine and other CIS markets.We are proud of our partners that include some of the biggest names in the health care industry: Abbott Laboratories (USA), Altana Pharma (Germany), Bristol-Myers Squibb (USA), Convatec (USA), Medinova (Switzerland), Mentholatum (UK), Molteni (Italy), Nepentes (Poland), Laboratoires UPSA (France), Laboratoires URGO (France), and Vitabiotics (UK).Our business model is to establish long-term partnerships with our distributors, pharmacies, suppliers as well as the medical community. We believe that by developing strong long term relationships we lower costs and increase effectiveness of operations for all parties involved.
Delta Medical today
Over 450 employees in Ukraine, and over 75 throughout the CIS
Business areas: Pharmaceuticals, healthcare and consumer products, marketing and promotion, regulatory and research
Independent, privately owned firm, not affiliated to any manufacturer
MissionTo provide people with innovational products necessary for health and beauty.
GoalTo occupy a dominant position in the CIS pharmaceutical market and render a complete services range to exclusive partners of Delta Medical.
Business modelDelta Medical business model is based upon continuous partner relations with manufacturers (as exclusive representative of goods and trade marks in Ukraine and CIS), suppliers, distributors, drug store nets, medical community. The basic operational principles are as follows:- promotion of innovational products demanded by the consumers;- participation in market formation;- medical/cosmetic drugs consumption standards improvement, active cooperation with the leading representatives of the medical and scientific community, state and private commercial institutions, funds and centers operating within the medical/cosmetic industry.